Imunon Inc (LTS:0HUZ)
$ 0.8201 -0.0411 (-4.77%) Market Cap: 11.49 Mil Enterprise Value: 7.57 Mil PE Ratio: 0 PB Ratio: 2.00 GF Score: 36/100

Q4 2021 Celsion Corp Earnings Call Transcript

Mar 31, 2022 / 03:00PM GMT
Release Date Price: $4.88
Operator

Good day, and welcome to Celsion's Fourth Quarter and Year-end 2021 Earnings Call. My name is Jess, and I will be your operator today. At this time, I would like to remind everyone that this call is being recorded.

I would now like to turn the conference over to Money Kosse, Life Science Advisors. Please go ahead, ma'am.

Unidentified Participant

Thank you, Jess, and good morning, everyone. Earlier today, Celsion issued a press release announcing financial results for the fourth quarter and year ended December 31, 2021. You may access that release on the company's website under the Investors tab. With us today are Michael Tardugno, Chairman, CEO and President of Celsion; and Jeff Church, Chief Financial Officer. Following management's prepared remarks, we will open the call for a question-and-answer session.

During this call, management will be making forward-looking statements regarding Celsion's expectations and projections about future events. Generally, forward-looking statements can be identified by terminologies such as expects, anticipates,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot